Department of Endocrinology and Metabolism, The Institute of Endocrinology, NHC Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
Eur J Endocrinol. 2021 Dec 2;186(1):115-122. doi: 10.1530/EJE-21-0975.
Longitudinal studies have investigated the effects of changing iodine status on thyroid disorders, but the effect of a transition from more than adequate iodine to adequate iodine on national changes in prevalence adjusted for changing risk factors remains unclear.
Two repeat nationwide surveys were conducted from 2009-2010 to 2015-2017 to assess changes in thyroid disorder prevalence and iodine status in China.
A multistage stratified random sampling method was used to obtain a nationally representative sample of urban adults aged 18 and older in mainland China in 2009 (n = 14 925) and 2015 (n = 12 553). Changes in thyroid disorder prevalence, urinary iodine concentration (UIC), and thyroid-stimulating hormone (TSH) levels were assessed. Logistic regression models were used to examine changes in prevalence over time.
The median UIC decreased significantly from 219.7 to 175.9 μg/L (P < 0.0001). The weighted prevalence of overt hyperthyroidism, subclinical hyperthyroidism, Graves' disease, and goitre decreased between 2009 and 2015 in the overall population (P < 0.05 for all). Despite no significant changes in subclinical hyperthyroidism or hypothyroidism or anti-thyroid peroxidase or anti-thyroglobulin antibody positivity prevalence, a significant increase in thyroid nodule prevalence (P < 0.0001) was found in the overall population. The 2.5th TSH percentile increased by 0.15 mIU/L (95% CI: 0.01 to 0.30 mIU/L, P = 0.04) from 2009 to 2015.
With the iodine status transition from more than adequate to adequate, thyroid disorder (except for thyroid nodules) prevalence remained stable or even decreased after adjusting for confounding factors among adults in mainland China between 2009 and 2015. Additional studies are needed to explore the reasons for the increased thyroid nodule prevalence.
已有研究探讨了碘营养状况改变对甲状腺疾病的影响,但从碘过量过渡到碘适量时,国家层面甲状腺疾病患病率变化是否会因不断变化的风险因素而受到影响,目前尚不清楚。
本研究于 2009-2010 年和 2015-2017 年进行了两次全国范围的重复调查,以评估中国甲状腺疾病患病率和碘营养状况的变化。
采用多阶段分层随机抽样方法,在中国大陆抽取年龄为 18 岁及以上的城市成年人作为代表性样本,于 2009 年(n = 14925)和 2015 年(n = 12553)进行调查。评估甲状腺疾病患病率、尿碘浓度(UIC)和促甲状腺激素(TSH)水平的变化。采用 logistic 回归模型检验随时间的患病率变化。
UIC 的中位数从 219.7μg/L 显著下降至 175.9μg/L(P < 0.0001)。总体人群中,2009 年至 2015 年期间,显性甲亢、亚临床甲亢、Graves 病和甲状腺肿的加权患病率下降(所有 P 值均<0.05)。尽管亚临床甲亢、甲减、抗甲状腺过氧化物酶抗体或抗甲状腺球蛋白抗体阳性率无显著变化,但甲状腺结节的患病率显著增加(P < 0.0001)。2009 年至 2015 年,2.5 分位 TSH 百分位值升高了 0.15mIU/L(95%CI:0.01~0.30mIU/L,P = 0.04)。
在中国,碘营养状况从碘过量过渡到碘适量,调整混杂因素后,2009 年至 2015 年期间,成年人的甲状腺疾病(除甲状腺结节外)患病率保持稳定或甚至下降。需要进一步研究来探讨甲状腺结节患病率增加的原因。